TRANSMEDICS GROUP INC

NASDAQ: TMDX (TransMedics Group, Inc.)

Kemas kini terakhir: 24 Dec, 2024, 2:24AM

62.65

0.95 (1.54%)

Penutupan Terdahulu 61.70
Buka 63.33
Jumlah Dagangan 923,580
Purata Dagangan (3B) 1,876,150
Modal Pasaran 2,102,627,968
Harga / Pendapatan (P/E TTM) 67.37
Harga / Pendapatan (P/E Ke hadapan) 58.14
Harga / Jualan (P/S) 5.96
Harga / Buku (P/B) 11.05
Julat 52 Minggu
59.72 (-4%) — 177.37 (183%)
Tarikh Pendapatan 24 Feb 2025 - 28 Feb 2025
Margin Keuntungan 8.14%
Margin Operasi (TTM) 3.61%
EPS Cair (TTM) 0.930
Pertumbuhan Hasil Suku Tahunan (YOY) 63.70%
Jumlah Hutang/Ekuiti (D/E MRQ) 246.83%
Nisbah Semasa (MRQ) 8.20
Aliran Tunai Operasi (OCF TTM) 37.44 M
Aliran Tunai Bebas Leveraj (LFCF TTM) -142.59 M
Pulangan Atas Aset (ROA TTM) 2.84%
Pulangan Atas Ekuiti (ROE TTM) 19.41%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Medical Devices (US) Bercampur Bercampur
Medical Devices (Global) Bercampur Bercampur
Stok TransMedics Group, Inc. Menurun Menaik

AISkor Stockmoo

0.6
Konsensus Penganalisis 1.0
Aktiviti Orang Dalam NA
Volatiliti Harga 4.5
Purata Bergerak Teknikal -1.0
Osilator Teknikal -2.0
Purata 0.63

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
TMDX 2 B - 67.37 11.05
PRCT 4 B - - 18.91
NARI 3 B - - 6.99
IRTC 3 B - - 39.31
RXST 1 B - - 5.00
ATEC 1 B - - 50.98

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Sektor Healthcare
Industri Medical Devices
Gaya Pelaburan Small Growth
% Dimiliki oleh Orang Dalam 3.21%
% Dimiliki oleh Institusi 113.48%
Julat 52 Minggu
59.72 (-4%) — 177.37 (183%)
Julat Harga Sasaran
75.00 (19%) — 125.00 (99%)
Tinggi 125.00 (Oppenheimer, 99.52%) Beli
Median 109.00 (73.98%)
Rendah 75.00 (JP Morgan, 19.71%) Pegang
Purata 106.14 (69.42%)
Jumlah 5 Beli, 2 Pegang
Harga Purata @ Panggilan 72.29
Syarikat Tarikh Harga Sasaran Panggilan Harga @ Panggilan
JP Morgan 17 Dec 2024 75.00 (19.71%) Pegang 65.71
29 Oct 2024 116.00 (85.16%) Beli 88.50
Baird 11 Dec 2024 120.00 (91.54%) Beli 67.36
29 Oct 2024 150.00 (139.43%) Beli 88.50
Piper Sandler 11 Dec 2024 90.00 (43.66%) Beli 67.36
20 Nov 2024 110.00 (75.58%) Beli 77.20
Oppenheimer 03 Dec 2024 125.00 (99.52%) Beli 71.44
29 Oct 2024 125.00 (99.52%) Beli 88.50
Needham 22 Nov 2024 109.00 (73.98%) Pegang 76.04
29 Oct 2024 109.00 (73.98%) Beli 88.50
Canaccord Genuity 20 Nov 2024 104.00 (66.00%) Beli 77.20
29 Oct 2024 109.00 (73.98%) Beli 88.50
TD Cowen 18 Nov 2024 120.00 (91.54%) Beli 80.93
Papar semua

Tiada data dalam julat masa ini.

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2025 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda